NDC 69968-0364-01 - Visine Dry Eye Relief Eye Drops
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69968-0364
- Requested NDC
- 69968-0364-01
- Package NDCs from labels
- 69968-0364-1, 69968-0364-01
- Manufacturer
- Kenvue Brands LLC
- Effective date
- 2024-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Visine Dry Eye Relief Eye Drops - Kenvue Brands LLC | Kenvue Brands LLC | 2024-11-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69968-0364-1 | Visine Dry Eye ReliefEye Drops | 15 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 15 | 4 | |
| 69968-0364-1 | Visine Dry Eye ReliefEye Drops | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69968-0364 | VISINE DRY EYE RELIEF EYE DROPS (POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KENVUE BRANDS LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241115_d9d3f000-3ce4-4ba2-a7fb-491b44eb3fa1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BMNP Kali Mur | KALIUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a546950-3f03-7abf-e063-6294a90a1968 | 2026-08-31 | Warnings | 660YQ98I10 |
| BMNP Nat Mur | NATRUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a57ccfd-ab6f-cb2c-e063-6394a90ae9e6 | 2026-08-31 | Warnings | 451W47IQ8X |
| REFRESH LIQUIGEL | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 4b8b2f6a-4b89-446c-9e5b-9b83c453a01d | 2026-08-28 | Warnings | M018 |
| Allergy Care | ADRENALINUM, RAGWEED, POLLEN (AMBROSIA ARTEMISIAEFOLIA), APIS MELLIFICA, ECHINACEA (ANGUSTIFOLIA), HISTAMINUM HYDROCHLORICUM, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, SULPHUR | NaturalCare | f3ca7f5a-1448-4670-ac02-b47ffb6c5585 | 2026-08-27 | Warnings | 451W47IQ8X |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Saline | SALINE NASAL SPRAY | Dynarex Corporation | 3247ae7d-554f-baab-e063-6294a90aa3ec | 2026-08-25 | Warnings | 451W47IQ8X |
| Electrolyte Plus | KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM | Deseret Biologicals, Inc. | e3564733-8b88-4753-9077-9d74004d8ec9 | 2026-08-25 | Warnings | 02F3473H9O 91MBZ8H3QO 451W47IQ8X PQ6CK8PD0R 660YQ98I10 |
| Mirexa Mini | MIREXA MINI | Oncora Pharma, LLC | ea48f64a-9a70-40df-ba25-098353273089 | 2026-08-25 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Aging Eye Formula | CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, GERMANIUM METALLICUM, NATRUM MURIATICUM | Nutritional Specialties, Inc. | d5b44f79-5299-4b31-ba45-0e511cdbe17c | 2026-08-24 | Warnings | 451W47IQ8X |
| Mycotox | GLANDULA SUPRARENALIS (BOVINE), SPLEEN (BOVINE), TABEBUIA IMPETIGINOSA (PAU D ARCO), THUJA OCCIDENTALIS, THYMUS (OVINE), THYROIDINUM (BOVINE), BORAX, COLCHICUM AUTUMNALE, LACTICUM ACIDUM, LYMPH NODE (SUIS), ARSENICUM ALBUM, ZINCUM METALLICUM, ASPERGILLUS NIGER, CANDIDA ALBICANS, CANDIDA PARAPSILOSIS, MUCOR RACEMOSUS, TORULA CEREVISIAE, ALTERNARIA TENUIS NEES, CANDIDA KRUSEI, RHIZOPUS NIGRICANS, CANDIDA TROPICALIS | Nutritional Specialties, Inc. | f19eca09-6733-41e7-b0a9-94d5a3d8a728 | 2026-08-24 | Warnings | 91MBZ8H3QO |
| Potassium Chloride | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ea55ded1-e076-43de-ad3c-c75e7d0a4ebc | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Cardinal Health 107, LLC | fea3ae21-3395-437e-b773-b180e1c98801 | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Coupler LLC | 598f61d7-a665-5d02-e063-6394a90a8905 | 2026-08-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | M018 |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | M018 3NXW29V3WO |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | M018 |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 451W47IQ8X 660YQ98I10 |
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | M018 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.